ACTRN12615000487516CompletedNot Applicable
A pilot study of the effect of oral curcumin on lymphocyte count in patients with clinical stage 0/1 chronic lymphocytic leukemia.
Southern Sydney Haematology0 sites20 target enrollmentStarted: May 15, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Non-randomised trial
- Primary Purpose
- Treatment
Eligibility Criteria
- Ages
- 40 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •Male or female patients over the age of 40 who have been diagnosed with stage 0/1 chronic lymphocytic leukemia (absolute lymphocyte count > 20x10 (9)lymphocytes/L).
Exclusion Criteria
- •1)Patients who are being actively treated.
- •2)Requirement for major surgery
- •3) Patients with diabetes
- •4) Patients on warfarin
- •5) Patients with GORD
Investigators
Similar Trials
Completed
Phase 2
The effects of curcumin on respiratory problems due to mustard gasChronic respiratory problems due to mustard gas intoxication.Chronic respiratory conditions due to chemicals, gases, fumes and vapoursIRCT2013091114521N2Baqiyatallah University of Medical Sciences80
Recruiting
Phase 2
Evaluation of the efficacy of oral curcumin on complex aphthousIRCT20100101002950N7Rasht University of Medical Sciences15
Active, not recruiting
Not Applicable
The impact of oral curcumin (Curcuma longa) on mycophenolic acid and metabolite pharmacokinetics in stable renal allograft recipients: exploratory investigation of the role of intestinal uridine-diphosphate-glucuronosyltransferases (UGTs) in in vivo mycophenolic acid disposition.Stable renal allograft recipientsEUCTR2007-003114-34-BEDepartment of Nephrology and Renal Transplantation, University Hospitals Leuven12
Not yet recruiting
Phase 3
Effect of oral curcumin on reducing the recurrence of nasal polyposisNasal polypIRCT20151123025202N24Hamedan University of Medical Sciences36
Unknown
Phase 2
An invivo study to evaluate the role of curcumin in oral pre-malignant lesions and gingivo-buccal cancersCTRI/2008/091/000193DBT90